ArticleBMC gastroenterology2026
An ensemble machine learning approach for predicting colorectal polyps using novel inflammatory markers.
Article in BMC gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study aimed to investigate the associations of two novel inflammatory-nutritional markers, the C-reactive Protein-Albumin-Lymphocyte (CALLY) index and C-reactive protein-to-lymphocyte ratio (CLR), with colorectal polyps, and to develop machine learning models for improved risk prediction.
methodsThe study conducted a retrospective analysis of 946 patients who underwent colonoscopy at the Second Qilu Hospital of Shandong University from 2023 to 2024. Clinical, laboratory, and endoscopic data were retrieved. Four machine learning models were developed: Random Forest (RF), Support Vector Machine (SVM), eXtreme Gradient Boosting (XGBoost), and Light Gradient Boosting Machine (LightGBM). Additionally, a Stacking ensemble model was constructed, integrating RF, XGBoost, and SVM with logistic regression as the meta-learner. Model performance was evaluated using metrics including the Area Under the Curve (AUC), accuracy, precision, recall, F1-score, and Kappa coefficient.
resultsBoth the CALLY index and CLR were significantly associated with the presence of colorectal polyps. The Stacking ensemble model achieved the highest predictive performance (AUC: 0.96), outperforming all individual base models. The RF, SVM, and XGBoost models also attained robust predictive capability (AUC: 0.75-0.76). By comparison, LightGBM exhibited suboptimal performance (AUC = 0.72). Feature importance analysis revealed CA19-9 as the top predictive factor.
conclusionElevated CLR and reduced CALLY index, together with traditional risk factors, synergistically contribute to colorectal polyp formation. The Stacking ensemble model serves as a highly accurate tool for identifying individuals at high risk of colorectal polyps, thereby facilitating targeted screening and timely early intervention. These findings support the incorporation of multi-dimensional inflammatory-nutritional biomarkers and machine learning strategies into clinical practice to optimize Colorectal Cancer (CRC) prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.